Doğrugörün, A. Et Al. 2023. Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3 , 95-100.

Doğrugörün, A., DOYUK KARTAL, E., & NAYMAN ALPAT, S., (2023). Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data. VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, 95-100.

Doğrugörün, Ayla, ELİF DOYUK KARTAL, And SAYGIN NAYMAN ALPAT. "Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data," VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, 95-100, 2023

Doğrugörün, Ayla Et Al. "Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, pp.95-100, 2023

Doğrugörün, A. DOYUK KARTAL, E. And NAYMAN ALPAT, S. (2023) . "Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data." VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL , vol.29, no.3, pp.95-100.

@article{article, author={Ayla Doğrugörün Et Al. }, title={Clinical Efficacy and Safety of Direct-Acting Antivirals in Chronic Hepatitis C Treatment: Real-World Data}, journal={VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL}, year=2023, pages={95-100} }